Given the aggravated SS-like symptoms and the decreased CD4+IL-10+ T cells in Il-27−/−NOD mice, we sought to investigate whether exogenous IL-27 treatment could up-regulate CD4+IL-10+ T cells and suppress inflammation in NOD mice. Here, IL10 is linked to synovial sarcoma.